It looks like this summer could be very profitable for peptide sellers.


More than a dozen peptides may soon be removed from the banned list, unlocking a new wave of demand for the industry.
If that happens, $HIMS could have another powerful growth narrative on its hands.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned